Rakesh Sutariya is the visionary Managing Director and CEO of Zenovel, bringing over 17 years of expertise in strategic marketing, operation management, business development, bio-analytical, clinical, and IT fields. He has successfully monitored, audited, and conducted over 1,000 clinical trials, while
helping design and execute complex studies for regulatory submissions. Under his leadership, Zenovel
has served over 150 global clients across 45 countries, supporting pharmaceutical development through GCP, GMP, and regulatory services. His leadership at Zenovel is marked by his hands-on approach,
overseeing team and collaborating closely with various departments to ensure the company’s growth
and success.
His approach to quality is driven by a commitment to ethical practices and maintaining the highest standards in every aspect of operations. For Mr. Rakesh, “Quality is not just about achieving results—it’s about doing so in a way that aligns with Zenovel’s core values of compassion, wisdom, and excellence”. He believes in empowering his team through continuous learning and development, ensuring they stay at the forefront of industry innovations while maintaining a keen focus on regulatory compliance
Mr. Rakesh’s client approach is proactive and collaborative. He views every client partnership as an extension of Zenovel’s mission to deliver safe, effective, and reliable pharmaceutical solutions. His philosophy centers on providing tailored, cost-effective services, and fostering open communication, ensuring that clients feel supported throughout their journey.
Clinical trials are crucial for drug development, but managing them is complex due to the vast amount of data and patient safety concerns. Zenovel uses innovative approaches like Risk-Based Monitoring (RBM) to streamline processes, prioritize quality, and enhance trial efficiency. This blog explores RBM’s significance in clinical trials and how
In the dynamic, rapidly changing environment of the pharmaceutical industry, product quality and regulatory compliance is mandated. Computer System Validation (CSV) is essential to that goal, since it demonstrates that computerized systems used in manufacturing, testing or managing data are reliable and compliant. This Zenovel guide gives an overview of
Pharmacokinetics (PK) is a key element of drug development, and describes how a drug interacts with the body by defining its absorption, distribution, metabolism and excretion (ADME). Knowing about PK is essential in drug development to establish the safety and efficacy of drugs (both new and generic). It is Zenovel’s
Over the past few decades, clinical trial monitoring has significantly changed from conventional on-site visits to remote and risk-based monitoring with technology. These developments revolutionized clinical trial conduct, with enhanced efficiency, cost reduction, and increased data quality. At Zenovel, we are leading the charge in excessing these innovations to optimize
The pharmaceutical industry is heavily regulated, and compliance with strict standards is crucial for operational excellence and avoiding penalties. To achieve regulatory readiness, pharmaceutical quality leaders use proactive preparation methods like mock inspections and compliance gap analysis. Zenovel guides companies through these processes to strengthen quality systems, enhance staff readiness,
Quality and compliance are paramount in the life sciences and pharmaceutical industry. Regulatory agencies like the U.S. Food and Drug Administration (FDA), European Medicines Agency (EMA), and the World Health Organization (WHO) have established rigorous requirements that rely on a holistic approach to quality assurance (QA) and validation. At Zenovel,
